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Abstract
We evaluated the impact of a lifestyle interven-
tion on the cardiometabolic risk profile of wom-
en participating in the Study on Diabetes and 
Associated Diseases in the Japanese-Brazilian 
Population in Bauru. This was a non-controlled 
experimental study including clinical and labo-
ratory values at baseline and after a 1-year inter-
vention period. 401 Japanese-Brazilian women 
were examined (age 60.8±11.7 years), and 365 
classified for metabolic syndrome (prevalence = 
50.6%). Subjects with metabolic syndrome were 
older than those without (63.0±10.0 vs. 56.7±11.6 
years, p < 0.01). After intervention, improvements 
in variables were found, except for C-reactive 
protein. Body mass index and waist circumfer-
ence decreased, but adiposity reduction was more 
pronounced in the abdominal region (87.0±9.7 
to 84.5±11.2cm, p < 0.001). Intervention-induced 
differences in total cholesterol, LDL, and post-
challenge glucose were significant; women who 
lost more than 5% body weight showed a better 
profile than those who did not. The lifestyle in-
tervention in Japanese-Brazilian women at high 
cardiometabolic risk improved anthropometric 
and laboratory parameters, but it is not known 
whether such benefits will persist and result in 
long-term reduction in cardiovascular events.
Nutritional Epidemiology; Metabolic Syndrome 
X; Population; Life Style
Introduction
Metabolic syndrome refers to a set of abnormali-
ties entailing greatly increased cardiovascular 
risk 1. Central obesity and insulin resistance have 
been identified as the main etiopathogenic fac-
tors that trigger disorders in glucose and lipid 
metabolism, endothelial dysfunction, increased 
blood pressure, and a proinflammatory and pro-
thrombotic state, among others. Despite some 
controversy in conceptualizing the syndrome, it 
is agreed that proposals for diagnostic criteria 
serve to call health professionals’ attention to the 
importance of convergent risk factors for cardio-
vascular diseases, currently the principal causes 
of mortality, including in developing countries 
like Brazil 2,3. 
After the World Health Organization (WHO) 
defined the metabolic syndrome, with criteria 
including a marker for insulin resistance, the 
National Cholesterol Education Program – Adult 
Panel III (NCEP-ATP III) proposed simple criteria 
for its diagnosis 4, capable of identifying individu-
als at high risk of type 2 diabetes mellitus and car-
diovascular diseases 5. The five diagnostic criteria 
for metabolic syndrome were abdominal obesity 
(waist circumference), triglycerides, HDL-cho-
lesterol, blood pressure, and fasting glucose. Bor-
derline blood glucose levels were subsequently 
reviewed by the American Heart Association and 
National Heart, Lung, and Blood Institute 6. The 
International Diabetes Federation (IDF) also took 
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a position on the metabolic syndrome, contend-
ing that central obesity – indicative of visceral fat 
deposits – should be a prerequisite for diagnos-
ing the syndrome 7. The IDF further emphasized 
that the waist circumference cutoff values pro-
posed by the NCEP were too high, particularly 
for Asian populations. Controversies concerning 
diagnostic criteria have hindered the compari-
son of prevalence rates for metabolic syndrome 
in various regions of the world, but the IDF esti-
mates that at least one-fourth of the world popu-
lation has the syndrome 7. 
Studies since 1993 in the resident Japanese-
Brazilian population in Bauru, São Paulo State, 
have shown high prevalence rates for the abnor-
malities comprising the metabolic syndrome 8,9, 
including one of the world’s highest diabetes 
rates 10. The harmful impact of glucose me-
tabolism disorders has been shown in terms of 
overall and cardiovascular mortality 11. Consid-
ering that half the population was found to have 
central obesity 12, a high frequency of metabolic 
syndrome was expected. Indeed, the metabolic 
syndrome, as defined by different criteria, af-
fected 48-58% of Japanese-Brazilians ³ 30 years 
13. Based on the hypothesis of the role of Western 
lifestyle in this condition, associations between 
metabolic syndrome and diet were investigated, 
identifying the role of fat intake in the syndrome 
14. In the cohort, followed from 1997 to 2000, 
consumption of red meat by Japanese-Brazil-
ian men was associated with the metabolic syn-
drome 15. Low physical activity was also com-
mon in this population 16.
These findings justified a lifestyle interven-
tion with dietary orientation and encouragement 
for physical activity in the Japanese-Brazilian 
community 17. Examples in the literature show 
the efficacy of healthy diet and physical activ-
ity for preventing diabetes 18,19 and improving 
the metabolic profile of individuals with meta-
bolic syndrome 20. The current study proposed to 
evaluate the impact of the first year of a commu-
nity-based intervention on cardiometabolic risk 
profile among women participating in the Study 
on Diabetes and Associated Diseases in the Japa-
nese-Brazilian Population in Bauru, São Paulo. 
The hypothesis was that reaching the program’s 
target – a reduction of at least 5% in body weight 
– would be associated with a decrease in both 
the mean values of the diagnostic parameters for 
metabolic syndrome and its prevalence.
Material and methods
Participants in the Study on Diabetes and Associ-
ated Diseases in the Japanese-Brazilian Popula-
tion in Bauru, conducted in 2000 10, who were 
located in 2005, were invited to participate in 
a third phase, a two-year lifestyle intervention, 
approved by the institutional review board of 
the Federal University in São Paulo (UNIFESP). 
In 2000, 1,330 Japanese-Brazilians participated 
(696 women), ³ 30 years of age, including both 
first-generation (born in Japan) and second-gen-
eration (children of the first generation, born in 
Brazil). Although the entire sample was the target 
of this third-phase intervention, losses to follow-
up (excluding the 101 deaths among participants 
of the study’s second phase) represented 38.4% 
of all the individuals examined in the year 2000 
(moved to another city or country, addresses not 
located, and refusals). Thus, 708 Japanese-Brazil-
ians (56.6% of whom were women) participated 
in the baseline evaluation (2005) of the third 
phase. These individuals were informed of the 
study’s objectives and signed a term of consent. 
A comparison of the group of participants and 
refusals showed no difference as to mean age 
or gender and generation distribution (data not 
shown). 
The study adopted an experimental, non-
controlled design, and the lifestyle intervention 
targeted all the participants. It included three 
moments of clinical and laboratory evalua-
tion, at baseline, after the first year of interven-
tion, and at the end of the second year (data not 
shown), when the individuals had blood samples 
drawn and consultations with the interdisciplin-
ary health team. The current analysis considered 
only the women (n = 401) (Figure 1) and the data 
from the first year of intervention.
Individuals presented (after at least 8 hours of 
fasting) at the Clinical Laboratory of the Sacred 
Heart University (USC) in Bauru, where blood 
samples were drawn to measure blood chemis-
try, hormone levels, and inflammatory markers, 
in addition to a 24-hour food recall interview. 
Prior to drawing blood samples, a capillary blood 
sample was drawn to screen for individuals for an 
oral glucose tolerance test with a 75g load (Glutol, 
Laborclin, Pinhais, Paraná State, Brazil). Individ-
uals with self-reported diabetes or capillary glu-
cose ³ 180mg/dl did not perform the OGTT, but 
only fasting blood glucose. All subjects were then 
scheduled for baseline outpatient appointments 
at the same institution, and were examined by 
the interdisciplinary team. Subjects underwent 
a complete medical examination (including an-
thropometry and blood pressure readings) and 
were informed as to their laboratory results. On 
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Figure 1
Diagram illustrating number of participants in phases 2000 
and 2005-2006 (intervention) in the Study on Diabetes and 
Associated Diseases in the Japanese-Brazilian Population in 
Bauru, São Paulo, Brazil.
Year Number of participants
1,330 (696 women – 100%)
(110 deaths)
512 address changes, not located,
and refusals
97 losses to follow-up
2000
 2005
2006
622
708
307 men
268 reexamined after intervention (38.5%)
365 classifiable as to metabolic syndrome
401 women (57.6%)
the same occasion, physical education profes-
sionals applied the international physical activity 
questionnaire (short form), previously validated 
for Brazil 21, and nutritionists applied a 48-hour 
food recall questionnaire (including items, num-
ber, and sizes of food portions). Participants then 
received verbal and written healthy lifestyle ori-
entation and were scheduled for new activities 
(see intervention strategy). 
Weight was measured using a digital scale 
(150kg capacity, accurate to 100g), barefoot and 
with a minimum of clothing, and height was 
measured using a portable stadiometer. Body 
mass index (BMI) was calculated by dividing 
weight by height-squared. Waist circumference 
was measured with a non-elastic tape measure, 
halfway between the last floating rib and the iliac 
crest, with the patient standing and the abdomen 
relaxed. Three blood pressure measurements 
were taken using an automatic instrument (Om-
ron model HEM-712C; Omron Health Care Inc., 
USA), adjusting the cuff to the brachial circum-
ference, after 5 minutes resting in sitting posi-
tion, with the right arm level with the left atrium. 
Final systolic and diastolic values were defined as 
the means of the last two measurements. 
Fasting blood samples were used to determine 
the plasma glucose levels, lipid profile (total cho-
lesterol, fractions, and triglycerides), uric acid, 
creatinine, insulin, and C-reactive protein (CRP). 
The levels were measured right after the blood 
samples were drawn, except for insulin and CRP, 
which were stored at -70º for subsequent mea-
surement. Blood glucose was measured using 
the glucose oxidase method, creatinine accord-
ing to the Jaffé reaction, and lipoproteins with 
enzymatic kits. CRP was measured by chemilu-
minescence and insulin by monoclonal antibody 
immunofluorometric assay.
Diagnosis of metabolic syndrome employed 
the IDF criteria 7, using waist circumference 
cutoff values specific to Japanese populations 
(³ 80cm for women) as a prerequisite, plus 2 oth-
er alterations in the diagnostic criteria. Excess 
weight among the Japanese-Brazilian women 
was defined as BMI ≥ 23kg/m2 22. 
Lifestyle intervention strategy
To reach the target of at least a 5% reduction in 
body weight, the intervention strategy was based 
on individual consultations, group sessions on 
healthy lifestyle, and community events with 
physical activities, administered by researchers 
from the UNIFESP and Bauru. The first year in-
cluded an individual nutritional consultation and 
two group sessions, coordinated by professional 
nutritionists and nutrition students and physical 
educators. The target for physical activity was a 
minimum of 150 minutes per week of moderate 
activities 23. Community events during this first 
year of intervention occurred on two weekends, 
including walks, stretch exercises, and localized 
gymnastics and dance. 
The individual nutritional appointment in-
cluded prescription of an adequate diet for indi-
vidual energy needs and nutritional status, with 
a food replacement list, besides orientation on 
healthy diet and stimulus for routine and leisure-
time physical activities. Diets were fractionated, 
with 50-60% of total calories coming from carbo-
hydrates, 10-15% from protein, and 20-30% from 
fat (< 10% from saturated fatty acids and > 20% 
from monounsaturated fatty acids). Daily choles-
terol intake < 300mg and fiber intake > 15g (foods 
naturally rich in fiber, like whole grains, fruits, 
and vegetables) were recommended, encourag-
ing typical Japanese meals rich in vegetables, 
with low fat, sugar, and sodium. A maximum of 
10 subjects participated in each group activity, 
which focused on the program’s food intake and 
physical activity goals, the importance of adher-
ence to healthy lifestyle, and observations by par-
ticipants. 
Evaluation of response to
intervention program 
Since the study design did not include a con-
trol group and the intervention was generalized 
(community intervention), as compared to the 
overall population, different variables were eva-
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luated at baseline and compared to those ob-
tained after a year of lifestyle intervention. In ad-
dition to body weight, the study’s principal target 
variables were variations in waist circumference, 
lipid profile, and glucose, insulin, and CRP lev-
els. Metabolic syndrome rates at baseline and 
after one year of intervention were compared. 
Statistical analysis
The effects on cardiometabolic risk profile in the 
Japanese-Brazilian population before and after 
one year in the program were analyzed using 
Stata 8.02 (Stata Corp., College Station, USA) and 
the Statistical Program for Social Science 9.0 (SPSS 
Inc., Chicago, USA). The means and standard de-
viations (SD) were estimated for the quantitative 
variables with normal distribution (anthropo-
metric and laboratory) at baseline and post-in-
tervention; these were compared using the Stu-
dent t-test or ANOVA when indicated. Variables 
without normal distribution were compared us-
ing log transformation. Correlations were tested 
between the percentage deltas of anthropomet-
ric and laboratory variables using Pearson’s cor-
relation coefficient. Absolute and relative varia-
tions in these variables based on the intervention 
were compared among the strata of individuals 
that achieved (versus did not achieve) the weight 
loss goal during the intervention. Frequencies of 
metabolic abnormalities were compared by the 
chi-squared test. Metabolic syndrome rates were 
calculated by point estimates and confidence in-
tervals (95%CI). Statistical significance was set at 
5% (p < 0.05).
Results
In 2005, the mean age of the 401 Japanese-Brazil-
ian women examined was 60.8 years (SD = 11.7 
years), and 86% were second-generation. Due to 
incomplete information on one or more of the 
diagnostic criteria for metabolic syndrome, of 
the 401 examined at baseline, it was possible to 
classify 365 (91%) for presence/absence of the 
syndrome. Women with complete anthropomet-
ric, clinical, and laboratory data, as compared to 
the others (n = 36) were younger (59.9 versus 68.4 
years) and showed a higher proportion of sec-
ond-generation individuals. An estimated 50.6% 
(95%CI: 45.3-55.8) of the classifiable women in 
2005 had the metabolic syndrome. 
Mean age of the women with metabolic syn-
drome in 2005 was statistically higher (63.0 years; 
SD = 10.0) than for women without the syndrome 
(56.7 years; SD = 11.6). No statistically significant 
association was observed between metabolic 
syndrome and generation (52.4% of first-genera-
tion versus 50.5% of second-generation women 
had the syndrome).
Table 1 shows the mean anthropometric, clin-
ical, and laboratory values for the 268 Japanese-
Brazilian women examined at both points in the 
study (pre- and post-intervention), stratified by 
presence of metabolic syndrome. Mean age, an-
thropometric, clinical, and laboratory values of 
women who failed to appear in 2006 (n = 97) did 
not differ from those who participated. Among 
the latter, most of the target variables improved, 
with the exception of CRP. The changes in triglyc-
erides and HDL-cholesterol were in the opposite 
direction from expected, but remained practical-
ly within normal range. Importantly, from 2005 
to 2006 there was a small but significant decrease 
in BMI and waist circumference for women with 
metabolic syndrome, and the most striking de-
crease was in abdominal adiposity. No significant 
correlations were detected (p > 0.05) between the 
percentage deltas in waist circumference and 
the deltas in laboratory variables used to define 
metabolic syndrome. Despite improvement in 
the mean anthropometric, laboratory, and blood 
pressure values, the rates of metabolic syndrome 
in participants at the two stages in the study did 
not decrease significantly (50% to 49%, p > 0.05). 
Table 2 shows the percentages or mean val-
ues of demographic, anthropometric, clinical, 
and laboratory variables for the 268 Japanese-
Brazilian women examined at the two stages in 
the study, according to alterations in their body 
weight during the study period. The majority 
(n = 149) were above the recommended weight; of 
these, 27 showed a decrease of at least 5% in body 
weight (18.1%). Analyzing the entire sample, the 
differences induced by the intervention were 
only statistically significant for waist circumfer-
ence and total cholesterol, LDL-cholesterol, and 
2-hour glucose tolerance, while women who lost 
≥ 5% of their body weight showed a better pro-
file in 2006 than those who remained the same 
or gained weight. The increase in triglycerides 
(see Table 1) was due to the women who gained 
weight.
Discussion
The current study investigates the cardiometa-
bolic risk profile of women from a population 
group with a known high prevalence of glucose 
and lipid metabolism disorders 8,9,10. By analyz-
ing the metabolic and hemodynamic abnormali-
ties jointly, i.e., based on the diagnosis of meta-
bolic syndrome, our findings are relevant in the 
sense of highlighting the increased cardiovascu-
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Table 1
Mean values (and standard deviations) for anthropometric, clinical, and laboratory variables in 268 Japanese-Brazilian women according to year of sample collection 
and presence of metabolic syndrome (MS).
 Variable  Year of sample p-value
 2005 2006
  Without MS With MS Without MS With MS Without MS With MS
 Body mass index (kg/m2) 22.0 (2.9) 26.6 (3.7) 21.8 (3.1) 26.3 (3.8) 0.182 0.002
 Waist circumference (cm) 79.2 (8.2) 91.1 (7.6) 78.6 (8.7) 89.8 (8.4) 0.133 0.000
 Systolic blood pressure (mmHg) 128.2 (20.1) 143.9 (23.2) 123.7 (19.3) 137.9 (22.1) 0.001 0.002
 Diastolic blood pressure (mmHg) 76.1 (11.7) 82.4 (11.6) 73.8 (11.8) 78.6 (11.5) 0.003 0.000
 Total cholesterol (mg/dL)* 211.5 (57.4) 227.3 (41.1) 196.1(47.3) 203.9 (39.1) 0.000 0.000
 Triglycerides (mg/dL) 111.5 (70.1) 179.0 (105.8) 121.4 (129.8) 198.4 (125.1) 0.238 0.038
 HDL-cholesterol (mg/dl)* 61.0 (11.7) 53.1 (11.4) 55.4 (13.3) 48.1 (15.2) 0.000 0.000
 LDL-cholesterol (mg/dL)* 126.3 (36.1) 136.5 (37.4) 116.0 (29.5) 115.9 (33.7) 0.001 0.000
 Fasting glucose (mg/dL)* 96.3 (12.4) 115.6 (40.4) 92.7 (14.1) 110.7(37.7) 0.001 0.135
 2-hr. post-load glucose (mg/dL)* 128.2 (37.1) 172.2 (50.4) 112.9 (30.1) 144.1 (43.7) 0.001 0.000
 Fasting insulin (mU/mL)* 3.4 (2.8) 8.5 (16.0) 4.2 (4.5) 10.8 (19.6) 0.076 0.010
 Creatinine (mg/dL)* 0.78 (1.00) 0.73 (0.83) 0.55 (0.10) 0.60 (0.16) 0.029 0.073
 Uric acid (mg/dL) 4.0 (3.8) 5.3 (4.6) 3.5 (1.0) 4.5 (1.3) 0.138 0.072
 C-reactive protein (mg/dL)* 0.18 (0.37) 0.27 (0.65) 0.17 (0.51) 0.26 (0.30) 0.811 0.956
* Variables log-transformed to perform statistical test. 
p-value refers to matched Student t test (without MS in 2005 versus without MS in 2006; with MS in 2005 versus with MS in 2006).
Table 2
Percentage or mean value (and standard deviation) of demographic, anthropometric, clinical, and laboratory variables in 268 Japanese-Brazilian women examined 
in 2005 and 2006, according to weight change during the period.
 Variable Weight change from 2005 to 2006 p-value *
 Decrease of 5 to Maintained Increase of 5 to
 15% (n = 30) (n = 221) 26% (n = 17)
 % with diabetes in 2005 ** 33.3 25.5 31.3 0.426
 % with hypertension in 2005 *** 55.6 66.5 87.5 0.745
 Age (years) 61.5 (9.8) 61.0 (10.9) 59.1 (10.5) 0.755
 Differences for values observed in 2006 minus those recorded in 2005
  Waist circumference (cm)  -4.70 (3.85) -0.70 (3.80) 2.35 (4.63) < 0.001
  Systolic blood pressure (mmHg)  -5.7 (14.2) -5.0 (19.0) -6.6 (14.3) 0.934
  Diastolic blood pressure (mmHg)  -3.9 (8.6) -2.9 (9.7) -2.3 (10.5) 0.846
  Total cholesterol (mg/dL) # -46.8 (36.6) -15.5 (37.7) -30.7 (44.8) <0.001
  HDL-cholesterol (mg/dL) # -7.6 (9.8) -4.5 (14.6) -10.2 (10.9) 0.191
  LDL-cholesterol (mg/dL) # -33.6 (36.4) -12.8 (36.2) -23.2 (40.0) 0.020
  Triglycerides (mg/dL) -28.7 (70.4) 17.2 (104.5) 32.7 (102.6) 0.065
  Fasting blood glucose (mg/dL) # -10.7 (23.0) -3.2 (18.6) -18.1 (78.0) 0.060
  2-hour blood glucose (mg/dL) # -45.3 (35.0) -18.5 (39.0) -29.9 (45.6) 0.018
  Fasting insulin (mU/mL) # -0.4 (2.9) 1.8 (7.7) 4.0 (9.4) 0.189
  Creatinine (mg/dL) # -0.1 (0.2) -0.2 (1.0) -0.1 (0.1) 0.487
  Uric acid (mg/dL) -0.5 (0.7) -0.7 (4.8) -0.2 (0.9) 0.855
  C-reactive protein (mg/dL) # 0.01 (0.18) -0.02 (0.66) 0.05 (0.59) 0.870
* p-value refers to chi-squared test or ANOVA. Bold print indicates signifi cant differences;
** Presence of diabetes: fasting blood glucose ≥ 126mg/dL or 2-hour blood glucose ≥ 200mg/dL or in use of glucose-lowering medication;
*** Presence of hypertension: systolic/ diastolic pressure ≥ 130/ 85mmHg or in use of anti-hypertensive medication;
# Variables log-transformed to perform statistical test.
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lar risk attributable to women of Japanese origin 
who have adopted the Western lifestyle. This af-
firmation is backed by the previous observation 
of a high frequency of cardiovascular diseases in 
this same population 24. Equally relevant is the 
observation that certain changes in habits – not 
always associated with weight reduction – are 
generally related to improvement in classical risk 
factors.
Importantly, the waist circumference values 
used in this study to diagnose women with meta-
bolic syndrome were lower than those often used 
in the international literature 4. Our research 
group has already suggested that the NCEP cri-
teria tend to under-diagnose abdominal obesity 
in Japanese-Brazilians 13. Consistent with this 
position, the present study used the IDF crite-
ria, setting 80cm as the normal limit for Japanese 
women 7. 
The consistent improvement observed in 
anthropometric, blood pressure, and laboratory 
(glucose and lipid) values did not hold true for se-
rum triglycerides or HDL-cholesterol, particularly 
among women with metabolic syndrome. There 
was an increase in triglycerides and a reduction 
in HDL, but both changes were slight. In wom-
en without metabolic syndrome, HDL dropped 
in parallel with total cholesterol and practically 
within the normal range. The dietary orienta-
tion (to reduce the percentage of fat intake, with 
a resulting increase in carbohydrates) may have 
contributed to this trend in the lipid profile. In-
terestingly, among women who lost weight, the 
mean triglyceride levels did not change. 
Half of the Japanese-Brazilian women living 
in a city in the State of São Paulo with high so-
cioeconomic development had metabolic syn-
drome in 2005, confirming the urgent need for 
intervention to minimize the associated risk. In 
men, a study comparing individuals with and 
without metabolic syndrome had already docu-
mented the increased risk of death, especially 
from cardiovascular diseases 25. The extent of the 
health problem in the Japanese-Brazilian popu-
lation in Bauru led our research group to opt for 
a community-based intervention. This choice in-
troduced a limitation in the current study, i.e., the 
absence of a control group. The working premise 
was that if a portion of the women with excess 
weight adhered to the program with changes in 
eating habits and physical activity and reduced 
their body weight, then a 5% weight loss target 
could be used as suggestive of adherence. This 
5% target has been used in other epidemiological 
studies 18,19, and in fact similar percentages were 
associated with metabolic and cardiovascular 
benefits and decreased mortality 26,27. Adopting 
this criterion, only 18.1% of the Japanese-Brazil-
ian women with BMI ≥ 23kg/m2 would have re-
duced their body weight in the current study. The 
usefulness of this marker to indicate adherence 
is somewhat limited, considering that metabolic 
benefits can be achieved even without reducing 
weight, due to the redistribution of body adiposi-
ty resulting from physical activity 28,29. When data 
on food intake and physical activity are available, 
adherence to the intervention program can be 
evaluated more thoroughly. 
The decrease in the sample from 2000 to 2005 
was due to deaths, address changes, and refus-
als after being informed of the study’s objectives. 
Due to the considerable morbidity in this popu-
lation, high mortality was expected. It is also not 
surprising that adult individuals would be reluc-
tant to change their lifestyle. One cannot rule out 
the possibility of a selection bias in the current 
study, which could have included participants 
more prone to switching to more healthy living 
habits. However, the response to the proposed 
program was heterogeneous, since some wom-
en gained weight, others lost weight, and some 
remained the same. Difficulties in implement-
ing behavior changes and sustaining weight loss 
have been observed consistently in other lifestyle 
intervention studies. 
The didactic plan set for the Japanese-Brazil-
ian population was based on prior observations 
in this same group that the dietary fat content 
was relatively high as compared to their country 
of origin 30. In addition, considering the inter-
national recommendations and potential bene-
fits of fiber intake on glucose and lipid metabo-
lism 31, this plan was adopted. However, in the 
Japanese-Brazilian cohort followed for seven 
years, consumption of red meat was only associ-
ated with metabolic syndrome in men, and there 
was no clear explication for the absence of this 
association in women 15. At any rate, this finding 
in Japanese-Brazilian men is consistent with oth-
er studies showing a direct association between 
frequent red meat consumption and myocardial 
infarction in men 32.
Metabolic disorders in women – with in-
creased cardiovascular risk – have become an 
important public health concern. The decreasing 
cardiovascular mortality rates reported in vari-
ous studies occurred to a lesser degree or disap-
peared in the presence of diabetes, as is the case 
for women. Epidemiological data for the United 
States show that cardiovascular mortality in dia-
betic women has not decreased, or has even in-
creased 33. A similar situation may be reported in 
women with metabolic syndrome, in whom the 
range of metabolic abnormalities is even wider.
In summary, a simple lifestyle intervention 
program was implemented here, based on a 
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healthy, low-fat, high-fiber diet, associated with 
physical activity, in a sample of Japanese-Brazil-
ian women with high cardiovascular risk due to 
metabolic syndrome. The findings generally sug-
gest benefits in the women’s anthropometric and 
laboratory profile. It is not known whether these 
benefits will persist or will be associated with a 
reduction in cardiovascular events in the long 
term. Similar initiatives should be developed in 
other Brazilian population segments, since car-
diovascular diseases are the country’s principal 
cause of mortality.
Resumo
Avaliou-se o impacto de intervenção no estilo de vida 
no perfil de risco cardiometabólico de mulheres parti-
cipantes do Estudo de Diabetes e Doenças Associadas 
na População Nipo-Brasileira de Bauru. O delinea-
mento foi experimental não-controlado, incluindo 
avaliação clínico-laboratorial basal e um ano após 
a intervenção. Examinaram-se 401 nipo-brasileiras 
(60,8 ± 11,7 anos) sendo 365 classificáveis quanto à 
presença de síndrome metabólica, estimada em 50,6%. 
Portadoras de síndrome metabólica eram mais velhas 
que aquelas sem a síndrome (63,0 ± 10,0 vs. 56,7 ± 11,6 
anos; p < 0,01). A intervenção associou-se à melhora 
nas variáveis avaliadas exceto na proteína C reativa. 
O índice de massa corporal e a cintura caíram, sendo 
a redução da adiposidade mais marcante na região 
abdominal (87,0 ± 9,7 para 84,5 ± 11,2cm; p < 0,001). 
As diferenças induzidas pela intervenção nos níveis 
de colesterol total, LDL e glicose pós-sobrecarga foram 
significantes; mulheres que reduziram ≥ 5% do peso 
apresentaram melhor perfil que as que mantiveram 
ou ganharam. Programa de intervenção no estilo de 
vida em nipo-brasileiras de alto risco cardiometabó-
lico, melhorou o perfil antropométrico e bioquímico, 
porém, se desconhece se serão duradouros, reduzindo 
eventos cardiovasculares em longo prazo.
Epidemiologia Nutricional; Síndrome X Metabólica; 
População; Estilo de Vida
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